Your browser doesn't support javascript.
loading
EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation.
Kautzner, Josef; Neuzil, Petr; Lambert, Hendrik; Peichl, Petr; Petru, Jan; Cihak, Robert; Skoda, Jan; Wichterle, Dan; Wissner, Erik; Yulzari, Aude; Kuck, Karl-Heinz.
Afiliação
  • Kautzner J; Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, Prague 14201, Czech Republic josef.kautzner@ikem.cz.
  • Neuzil P; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
  • Lambert H; St Jude Medical GVA, Geneva, Switzerland.
  • Peichl P; Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, Prague 14201, Czech Republic.
  • Petru J; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
  • Cihak R; Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, Prague 14201, Czech Republic.
  • Skoda J; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
  • Wichterle D; Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, Prague 14201, Czech Republic.
  • Wissner E; Abt Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany.
  • Yulzari A; St Jude Medical GVA, Geneva, Switzerland.
  • Kuck KH; Abt Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany.
Europace ; 17(8): 1229-35, 2015 Aug.
Article em En | MEDLINE | ID: mdl-26041872
ABSTRACT

AIMS:

A challenge of pulmonary vein isolation (PVI) in catheter ablation for paroxysmal atrial fibrillation (PAF) is electrical reconnection of the PV. EFFICAS I showed correlation between contact force (CF) parameters and PV durable isolation but no prospective evaluation was made. EFFICAS II was a multicentre study to prospectively assess the impact of CF guidance for an effective reduction of PVI gaps. METHODS AND

RESULTS:

Pulmonary vein isolation using a radiofrequency (RF) ablation catheter with an integrated force sensor (TactiCath™) was performed in patients with PAF. Operators were provided EFFICAS I-based CF guidelines [target 20 g, range 10-30 g, minimum 400 g s force-time integral (FTI)]. Conduction gaps were assessed by remapping of PVs after 3 months, and gap rate was compared with EFFICAS I outcome. At follow up, 24 patients had 85% of PVs remaining isolated, compared with 72% in EFFICAS I (P = 0.037) in which CF guidelines were not used. The remaining 15% of gaps correlated to the number of catheter moves at creating the PVI line, quantified as Continuity Index. For PV lines with contiguous lesions and low catheter moves, durable isolation was 81% in EFFICAS I and 98% in EFFICAS II (P = 0.005). At index procedure, the number of lesions was reduced by 15% in EFFICAS II vs. EFFICAS I.

CONCLUSION:

The use of CF with the above guidelines and contiguous deployment of RF lesions in EFFICAS II study resulted in more durable PVI in catheter ablation of PAF.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Veias Pulmonares / Fibrilação Atrial / Ablação por Cateter / Mapeamento Potencial de Superfície Corporal / Sistema de Condução Cardíaco Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Veias Pulmonares / Fibrilação Atrial / Ablação por Cateter / Mapeamento Potencial de Superfície Corporal / Sistema de Condução Cardíaco Idioma: En Ano de publicação: 2015 Tipo de documento: Article